GleamWall
中文EN

NVCR NovoCure Ltd

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1645113 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY12.9%
TTM net income YoY31.5%
TTM EPS YoY34.2%
Revenue 3-yr CAGR12.9%
Net income 3-yr CAGR—

Margins

Gross margin77.0%
Operating margin-17.2%
Net margin-16.8%
FCF margin-3.4%
EBITDA margin-14.8%

Returns

ROE-35.2%
ROA-11.1%
ROIC (approx.)-77.8%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets57.7%
Debt / equity0.00x
Current ratio2.49x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.01x
Accruals ratio-11.1%
Payout ratio—
Capex / revenue3.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$655.35M$605.22M
Cost of revenue$166.88M$137.18M
Gross profit$488.47M$468.04M
R&D expense$224.54M$209.65M
SG&A expense$177.67M$189.83M
Operating income-$153.80M-$170.50M
Interest expense$22.22M$11.66M
Pretax income-$136.25M-$131.16M
Income tax-$23,000$37.47M
Net income-$136.23M-$168.63M
EBITDA-$139.15M-$159.26M
EPS (basic)-1.22-1.56
EPS (diluted)-1.22-1.56
Weighted avg. shares (diluted)111.47M107.83M
Balance sheet
Cash & equivalents$93.55M$166.09M
Receivables$89.44M$74.23M
Inventory$41.11M$35.09M
Current assets$646.73M$1.11B
PP&E, net$77.61M$77.66M
Total assets$804.33M$1.24B
Current liabilities$223.23M$756.39M
Short-term debt$0—
Long-term debt$195.05M$97.30M
Total debt$195.05M$97.30M
Total liabilities$463.86M$880.61M
Shareholders' equity$340.47M$360.18M
Net debt$101.50M-$68.79M
Shares outstanding112.49M108.52M
Cash flow statement
Operating cash flow-$49.03M-$26.37M
Capital expenditure$26.65M$42.85M
Free cash flow-$75.68M-$69.22M
Investing cash flow$437.28M-$140.24M
Financing cash flow-$451.34M$90.31M
Depreciation & amortization$14.65M$11.23M
Stock-based compensation$104.83M$160.03M

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.